COVID Vaccine Information

  • The Centers for Disease Control (CDC) recommends everyone 6 months and older get a COVID-19 vaccination to help protect against COVID-19. Read more information on their recommendations.
  • COVID-19 vaccine appointments for ages 6 months to 17 are administered at pediatric offices. Appointments must be made by phone at (512) 901-4066. If you have questions about the vaccine for your child, please call your pediatrician’s office to schedule an appointment to discuss further.
  • Pfizer and Moderna COVID-19 vaccines are available for those 18 years old and older at all ADC pediatric, family and internal medicine clinic locations through the ADC Travel Clinic. Appointments are required for both new and established patients. Call (512) 901-4486 to make your appointment, or you can make the appointment online for those 12 years old and older. Walk-ins are not allowed.
  • The ADC Travel Clinic (located at North Austin Medical Center) is open for COVID and Flu vaccines daily from 9 am – 4 pm.  Appointments are recommended but walk-ins are welcome.  Call 512-901-4486 to schedule.

Bivalent vaccines are now available at all ADC locations!

The bivalent vaccines (which provides protection against the original strain as well as the new Omicron BA.4/BA.5 variants) can be administered to patients after completion of their primary series (which is the monovalent formulation) regimen per their age and CDC recommendations.

The current regimen is as follows for each formulation for most people:

NOVAVAX

  • A non mRNA COVID vaccine! Novavax formulation is currently offered only at the Travel Clinic office located at NAMC.
  • 12 and older receives a 2 dose series with 2nd dose administered 3 – 8 weeks later.
  • 12 and older, booster dose recommended of either Pfizer or Moderna BIVALENT dose at least 8 weeks (2 months) after 2nd
  • Novavax is a protein subunit, non-mRNA vaccine that is egg, preservative, latex and metal free

MODERNA

  • 6 mos. – 5 years receives a 2 dose monovalent series with 2nd dose administered 4 – 8 weeks later. NO boosters recommended at this time for this age group.
  • 6 and older receives a 2 dose monovalent series with 2nd dose administered 4 – 8 weeks later.
  • Booster dose recommended to 6 years and older to receive a Pfizer or Moderna BIVALENT dose at least 8 weeks (2 months) after the 2nd dose (of monovalent series)

PFIZER

  • 6 mos. – 4 years receives a 3 dose monovalent series with 2nd dose administered 3 – 8 weeks later then 3rd dose at least 8 weeks later. No boosters recommended at this time for this age group.
  • 5 and older receive a 2 dose monovalent series with 2nd dose administered 3 – 8 weeks later.
  • Booster dose recommended to 5years and older to receive Pfizer or Moderna BIVALENT dose at least 8 weeks (2 months) after 2nd

JANSSEN

  • Patients age 18 and older that received Janssen vaccine are recommended to receive a booster dose either Pfizer or Moderna BIVALENT dose at least 8 weeks (2 months) after previous dose.

The current regimen is as follows for each formulation for immunocompromised patients:

NOVAVAX

  • A non mRNA COVID vaccine
  • 12 and older receives a 2 dose series with 2nd dose administered 3 weeks later.
  • 12 and older, booster dose recommended of either Pfizer or Moderna BIVALENT dose at least 8 weeks (2 months) after 2nd

MODERNA

  • 6 mos. – 5 years receives a 3 dose monovalent series with 2nd dose administered 4 weeks then 3rd dose 4 weeks later. NO boosters recommended at this time for this age group.
  • 6 years and older receives a 3 dose monovalent series with 2nd dose administered 4 weeks then 3rd dose 4 weeks later. Booster dose recommended to 6 years and older to receive a Pfizer or Moderna BIVALENT dose at least 8 weeks (2 months) after the 3rd dose (of monovalent series)

PFIZER

  • 6 mos. – 4 years receives a 3 dose monovalent series with 2nd dose administered 3 weeks later then 3rd dose at least 4 weeks later. No boosters recommended at this time for this age.
  • 5 years and older receive a 3 dose monovalent series with 2nd dose administered 3 weeks later then 3rd dose 4 weeks later. A booster dose of the MONOVALENT formulations can be administered at least 3 months later.
  • Booster dose recommended to 5years and older to receive Pfizer or Moderna BIVALENT dose at least 8 weeks (2 months) after 3rd dose.